MFMolly Fisher

Molly Fisher

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Molly Fisher has a total of 110 co-authors. Here are the top co-authors by number of shared publications:

  • Ladan Golestaneh

    Division of Nephrology, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York

    5 shared publications
  • Michael J. Ross

    Division of Nephrology, Albert Einstein College of Medicine, Montefiore Health System, Bronx, NY

    4 shared publications
  • Christina M. Wyatt

    Division of Nephrology, Duke University

    3 shared publications
  • David B. Hanna

    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Montefiore Health System, Bronx, NY

    3 shared publications
  • Maria Coco

    Albert Einstein College of Medicine, Bronx, New York

    3 shared publications
  • Matthew K. Abramowitz

    Division of Nephrology, Albert Einstein College of Medicine, Montefiore Health System, Bronx, NY

    3 shared publications

Latest Publications

  • Open Access

    Extracellular Vesicle Surface Marker Profiling and the Road to Recovery after Acute Kidney Injury

    by Molly C. Fisher, Surjya Narayan Dash, Dylan Burger

    Was not provided for this article.

  • Open Access

    Serum Biomarkers of Macrophage Activation and Incident CKD in People With and Without HIV: Findings From the MACS-WIHS Combined Cohort Study

    by Molly C Fisher, David B Hanna, Donald R Hoover, Qiuhu Shi, Anjali Sharma, Michelle M Estrella, Todd T Brown, Michelle Floris-Moore, Frank J Palella, Jordan E Lake, et al.

    Background: Macrophages play an important role in kidney inflammation and fibrosis. Circulating biomarkers of macrophage activation are elevated in people with HIV (PWH). We therefore determined their associations with kidney function and chronic kidney disease (CKD) risk in people with and without HIV. Methods: We analyzed data from 2 prospective cohorts: the Women's Interagency HIV Study and Multicenter AIDS Cohort Study. Serum concentrations of soluble (s)CD14, sCD163, galectin-3 (Gal-3) and Gal-3 binding protein (Gal-3BP) were measured between 2004 and 2006. We examined each biomarker's association with estimated glomerular filtration rate (eGFR) using multivariable linear regression and with incident CKD (2 consecutive eGFR <60 mL/min/1.73 m2) using cause-specific Cox proportional hazards models, adjusting for sociodemographics, CKD risk factors, and HIV-related factors. Results: Among 1284 participants, 61% were women, 70% were PWH, of whom 59% were virally suppressed (HIV RNA < 200 copies/mL); median eGFR was 93 mL/min/1.73 m2 at baseline. All macrophage biomarker concentrations were higher in PWH versus without HIV (P < .05). Cross-sectionally, higher concentrations of sCD14 and Gal-3 were independently associated with lower eGFR (P < .001). Over a median follow-up of 14.2 years, incident CKD occurred in 23% of PWH and in 11% without HIV. Each standard deviation higher concentration of sCD14 and Gal-3BP was independently associated with 22% and 29% increased CKD risk, respectively. Associations for sCD163 and Gal-3 were attenuated after multivariable adjustment. Findings were similar in analyses restricted to PWH. Conclusions: Macrophage activation may mark and/or contribute to CKD development. Studies are needed to determine whether targeting immune activation improves kidney health in PWH.

  • HIV-associated kidney diseases: progress, gaps, and future directions

    by Molly C. Fisher, Christina M. Wyatt, Michelle M. Estrella

    SUMMARY: With improved uptake and earlier initiation of effective antiretroviral therapy (ART), the landscape of chronic kidney disease (CKD) among people with HIV (PWH) has substantially evolved. HIV-driven kidney diseases, particularly HIV-associated nephropathy (HIVAN), have largely disappeared in regions with widespread ART availability. However, CKD remains an important comorbidity among PWH because of the increased prevalence of age-related conditions such as diabetes and hypertension, which are established CKD risk factors. Whether contemporary ART regimens that have lower metabolic and kidney toxicity will lower this burden over time remains unclear. In low-resourced areas, these age-related conditions are compounded by persistent disparities in access to ART, co-infections, and limited resources for CKD screening and management. Early detection and management of CKD are crucial to slowing CKD progression and averting its related cardiovascular complications. The past several years have ushered in several new therapies that both lower the risk for CKD progression and adverse cardiovascular events, underscoring the importance of kidney function and albuminuria testing in those at high risk of CKD or CKD progression. For PWH who unfortunately progress to end-stage kidney disease, kidney transplantation now offers improved survival but requires careful management of immunosuppressive regimens and infectious complications. This review will discuss the current understanding of the epidemiology, pathogenesis, diagnosis, and management of kidney diseases in PWH.


  • Associations of repeated measures of plasma biomarkers of kidney tubular health with longitudinal kidney function in people with HIV

    by Molly C. Fisher, Rebecca Scherzer, Merve Postalcioglu, Teresa K. Chen, Simon B. Ascher, Jordan E. Lake, Michelle Floris-Morre, Seble Kassaye, Igho Ofotokun, Jodie Dionne, et al.

    Background: In people with HIV (PWH), urine tubular biomarkers have been linked to kidney function decline, but urine concentration variability limits their clinical utility. Plasma biomarkers may offer more stable indicators of kidney tubular health. Methods: We conducted a case–cohort study of 440 PWH from the Multicenter AIDS Cohort Study (MACS)/Women's Interagency HIV Study (WIHS) Combined Cohort Study (MWCCS). Cases developed rapid kidney function decline [RKFD: ≥30% estimated glomerular filtration rate (eGFR) reduction]. We measured plasma biomarkers of tubular injury [kidney injury molecule-1 (KIM-1)], inflammation [tumor necrosis factor receptor-1 (TNFr1) and tumor necrosis factor receptor-2 (TNFr2)], and synthetic function [uromodulin (UMOD) and epidermal growth factor (EGF)] at baseline and year 2. Associations with RKFD were assessed using multivariable risk regression, adjusting for chronic kidney disease (CKD) and HIV-related risk factors, eGFR, and albuminuria. In a random sub-cohort, linear mixed models evaluated associations with annualized eGFR change. Results: At baseline, median age was 49 years; 33% were women; 69% were virally suppressed; eGFR was similar in cases vs. noncases (93 vs. 94 ml/min/1.73 m 2 ). Over a median of 4.5 years, 172 RKFD events occurred. Each 1-standard deviation higher baseline KIM-1, TNFr1, TNFr2, UMOD, and EGF level was associated with adjusted relative risks (RR) for RKFD of 1.26 [95% confidence interval (CI): 1.15–1.39], 1.39 (1.24–1.55), 1.40 (1.24–1.57), 0.84 (0.77–0.93), and 0.85 (0.78–0.92), respectively. Findings were similar at year 2 and for 2-year biomarker changes. In joint models, baseline KIM-1, TNFr2, and UMOD remained independently associated with RKFD [RR: 1.19 (1.08–1.31), 1.27 (1.12–1.43), and 0.86 (0.78–0.95)], respectively. No biomarker was associated with annualized eGFR change in the sub-cohort. Conclusion: In PWH, plasma biomarkers reflecting impaired kidney tubular health were independently associated with RKFD and may be useful prognosticators of adverse kidney outcomes.

  • Brief Report: Preadmission VACS Index as a Predictor of Hospital Acute Kidney Injury in People With HIV

    by Molly C. Do Fisher, David B. Hanna, Melissa Fazzari, Uriel R. Felsen, Christina M. Wyatt, Matthew K. Abramowitz, Michael J. Ross

    Background: The Veterans Aging Cohort Study (VACS) Index is a summary measure of routinely obtained clinical variables that predicts numerous health outcomes. Because there are currently no tools to predict acute kidney injury (AKI) in people with HIV (PWH), we investigated the association of preadmission VACS Index with hospital AKI in PWH. Methods: We conducted an observational study of PWH hospitalized in a New York City health system between 2010 and 2019. The VACS Index, calculated using outpatient laboratory values within 8–365 days of admission, was examined continuously and in quartiles. Multivariable Cox proportional hazards models, adjusting for sociodemographic factors, comorbidities, and ICU admission, determined the association of the VACS Index with AKI. Results: Among 1186 PWH, median age was 53 years, 43.5% were women, 86.2% were Hispanic or Black, 23.1% were coinfected with hepatitis C, and 65% were virally suppressed (P for trend <0.001). Conclusions: Preadmission VACS Index is associated with hospital AKI. Use of the VACS Index may allow for early identification of PWH at risk for AKI and initiation of preventative strategies. These findings should be externally validated in other health systems, including its predictive performance in specific hospital settings.

  • Open Access

    Improving Blood Pressure in High-Risk Patients With CKD Using an Interdisciplinary Remote Hypertension Program

    by Molly C. Fisher, Sharon Rikin, Sonali Gupta, Jeremy Awori, Michel Terzibachi, Gracy Sebastian, Allison Stark, Tanya S. Johns


  • An Update on Viral Infection-Associated Collapsing Glomerulopathy

    by Molly Fisher, Michael Ross, Lanny DiFranza, Kimberly Reidy


  • Open Access

    AKI in a Patient with Treated HIV Infection

    by Krishna Mohita Kuruvada, Lanny DiFranza, Molly Fisher

    Visual Abstract Export


  • Association of HIV and viral suppression status with hospital acute kidney injury in the era of antiretroviral therapy

    by Molly C. Fisher, Melissa J. Fazzari, Uriel R. Felsen, David B. Hanna, Nataliya Tappan, Christina M. Wyatt, Matthew K. Abramowitz, Michael J. Ross


  • Association of marijuana, tobacco and alcohol use with estimated glomerular filtration rate in women living with HIV and women without HIV

    by Molly C. Fisher, Donald R. Hoover, Qiuhu Shi, Anjali Sharma, Michelle M. Estrella, Adaora Adimora, Maria Alcaide, Lauren F. Collins, Audrey French, Wei Gao, et al.

    Objective: Marijuana, tobacco and alcohol use are prevalent among people with HIV and may adversely affect kidney function in this population. We determined the association of use of these substances with estimated glomerular filtration rate (eGFR) among women with HIV (WWH) and women without HIV. Design: We undertook a repeated measures study of 1043 WWH and 469 women without HIV within the United States Women's Interagency HIV Study, a multicenter, prospective cohort of HIV-seropositive and HIV-seronegative women. Methods: We quantified substance exposures using semi-annual questionnaires. Using pooled eGFR data from 2009 to 2019, we used linear regression models with multivariable generalized estimating equations to ascertain associations between current and cumulative substance use exposures with eGFR, adjusting for sociodemographics, chronic kidney disease risk factors and HIV-related factors. Results: Marijuana use of 1–14 days/month versus 0 days/month was associated with 3.34 ml/min per 1.73 m2 [95% confidence interval (CI) −6.63, −0.06] lower eGFR and marijuana use of >0.02–1.6 marijuana-years versus 0–0.2 marijuana-years was associated with 3.61 ml/min per 1.73 m2 (95% CI −5.97, −1.24) lower eGFR. Tobacco use was not independently associated with eGFR. Alcohol use of seven or more drinks/week versus no drinks/week was associated with 5.41 ml/min per 1.73 m2 (95% CI 2.34, 8.48) higher eGFR and alcohol use of >0.7–4.27 drink-years and >4.27 drink-years versus 0–0.7 drink-years were associated with 2.85 ml/min per 1.73 m2 (95% CI 0.55, 5.15) and 2.26 ml/min per 1.73 m2 (95% CI 0.33, 4.20) higher eGFR, respectively. Conclusion: Among a large cohort of WWH and women without HIV, marijuana use was associated with a lower eGFR while alcohol use was associated with a higher eGFR.